AI Models Advance Protein Mapping and Genome Analysis for Cellular Research

New AI models are significantly advancing life sciences by enabling virtual spatial-proteomics maps and improving genome interpretation. A Stanford model predicts protein biomarkers from pathology slides, while Google DeepMind's AlphaGenome analyzes large DNA segments to understand regulatory effects in the non-coding genome. These tools offer powerful new capabilities for understanding cellular functions and could accelerate drug discovery.